ncd 38

NCD38 is a selective LSD1 (lysine-specific demethylase 1) inhibitor that activates super-enhancers and myeloid cell development programmes, exhibiting anti-leukaemia activity.

NCD38 TFA serves as a selective inhibitor of LSD1 [1] [2].

Hexamethonium tartrate is a nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Anti-Human-CD38 Antibody (Daratumumab hexabody) is an antibody. Its expression system is HEK293 cells, and the isotype control is IgG1, Kappa.